AFP and hepatocellular carcinoma: Consistently, in a retrospective study recruiting 104 HCC patients with 104 matched non-HCC individuals, the elevation of AFP-L3 was present before the tumor became visible by imaging even though very low AFP levels could be detected, suggesting that AFP-L3 may serve as an early predictive HCC marker [34].